Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-03-17 10:00 am Purchase | 13G | TIZIANA LIFE SCIENCES LTD TLSA | Empery Asset Management LP | 15,175,000 9.9% | 15,175,000 (New Position) | View |
2020-02-11 2:16 pm Purchase | 13G | MOLECULIN BIOTECH INC PAR MBRX | Empery Asset Management LP | 3,750,000 7.05% | 3,750,000 (New Position) | View |
2020-02-03 11:07 am Purchase | 13G | NUWELLIS INC NUWE | Empery Asset Management LP | 3,228,205 9.99% | 3,228,205 (New Position) | View |
2020-01-28 1:13 pm Sale | 13G | APPLIED DNA SCIENCES INC P APDN | Empery Asset Management LP | 6,876 0.2% | -848,477 (-99.20%) | View |
2020-01-28 1:08 pm Unchanged | 13G | 22nd Century Group Inc. XXII | Empery Asset Management LP | 10,543,211 4.99% | 0 (Unchanged) | View |
2020-01-28 1:02 pm Purchase | 13G | YIELD10 BIOSCIENCE, INC YTEN | Empery Asset Management LP | 15,227,777 4.99% | 4,950,000 (+48.16%) | View |
2020-01-27 12:11 pm Purchase | 13G | NANOVIRICIDES INC PAR $0.0 NNVC | Empery Asset Management LP | 640,000 9.51% | 640,000 (New Position) | View |
2020-01-27 12:09 pm Purchase | 13G | AETHLON MEDICAL INC AEMD | Empery Asset Management LP | 1,040,894 7.73% | 253,349 (+32.17%) | View |
2020-01-27 11:36 am Unchanged | 13G | GUARDION HEALTH SCIENCES INC C GHSI | Empery Asset Management LP | 7,200,000 4.99% | 0 (Unchanged) | View |
2020-01-27 11:33 am Purchase | 13G | TITAN PHARMACEUTICALS INC DEL TTNP | Empery Asset Management LP | 7,922,395 4.99% | 4,589,062 (+137.67%) | View |
2020-01-27 11:31 am Unchanged | 13G | AETHLON MEDICAL INC AEMD | Empery Asset Management LP | 787,545 4.99% | 0 (Unchanged) | View |
2020-01-23 3:10 pm Purchase | 13G | KINTARA THERAPEUTICS INC N KTRA | Empery Asset Management LP | 1,440,125 4.99% | 1,147,625 (+392.35%) | View |
2020-01-23 3:08 pm Sale | 13G | RESHAPE LIFESCIENCES INC C RSLS | Empery Asset Management LP | 525,000 4.99% | -25,000 (-4.55%) | View |
2020-01-23 3:07 pm Sale | 13G | AMPIO PHARMACEUTICALS INC AMPE | Empery Asset Management LP | 3,667,514 2.31% | -8,832,486 (-70.66%) | View |
2020-01-23 3:05 pm Unchanged | 13G | NOVABAY PHARMACEUTICALS INC CO NBY | Empery Asset Management LP | 2,098,566 4.99% | 0 (Unchanged) | View |
2020-01-23 3:03 pm Unchanged | 13G | AETERNA ZENTARIS INC NO PA AEZS | Empery Asset Management LP | 1,661,000 4.99% | 0 (Unchanged) | View |
2020-01-23 3:02 pm Sale | 13G | Ocugen Inc. OCGN | Empery Asset Management LP | 2,982,456 4.99% | -15,508,767 (-83.87%) | View |
2020-01-23 3:00 pm Purchase | 13G | BENITEC BIOPHARMA LTD SPONSORE BNTC | Empery Asset Management LP | 32,128,800 4.99% | 32,128,800 (New Position) | View |
2020-01-21 11:38 am Sale | 13G | AYALA PHARMACEUTICALS, INC. CO ADXS | Empery Asset Management LP | 0 0% | -600,000 (Position Closed) | View |
2020-01-21 11:36 am Sale | 13G | INSPIREMD INC NSPR | Empery Asset Management LP | 0 0% | -100,000 (Position Closed) | View |